Literature DB >> 19795854

Further evidence for 2-alkyl-2-carboxyazetidines as gamma-turn inducers.

José Luis Baeza1, Guillermo Gerona-Navarro, Kevin Thompson, M Jesús Pérez de Vega, Lourdes Infantes, M Teresa García-López, Rosario González-Muñiz, Mercedes Martín-Martínez.   

Abstract

Reverse turns, a common motif in proteins and peptides, have attracted attention due to their relevance in a wide variety of biological processes. In an attempt to artificially imitate and stabilize these turns in short peptides, we have developed versatile synthetic methodologies for the preparation of 2-alkyl-2-carboxyazetidines and incorporated them into the i + 1 position of model tetrapeptides, where they have shown a tendency to induce gamma-turns. However, to ascertain the general utility of these restricted amino acids as gamma-type reverse turn inducers, it was then required to study the conformational preferences when located at other positions. To this end, model tetrapeptides R-CO-Ala-Xaa-NHMe, containing differently substituted azetidine moieties (Xaa = Aze, 2-MeAze, 2-BnAze) at the i + 2 position, were synthesized and subjected to a thorough conformational analysis. The theoretical and experimental results obtained, including the X-ray diffraction structure of a dipeptide derivative containing this skeleton, provide evidence that the 2-alkyl-2-carboxyazetidine scaffold is able to efficiently induce gamma-turns when incorporated into these short peptides, irrespective of their localization in the peptide chain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795854     DOI: 10.1021/jo901712x

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors.

Authors:  Paula Pérez-Faginas; M Teresa Aranda; M Teresa García-López; Robert Snoeck; Graciela Andrei; Jan Balzarini; Rosario González-Muñiz
Journal:  Bioorg Med Chem       Date:  2010-12-30       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.